Trials / Terminated
TerminatedNCT04854889
Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic Anemia
Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic Anemia (LODACA): a Phase 2, Single-arm, Open-label Study
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase 2, single-center, single-arm, open-label trial. Simon's two-stage design is performed to evaluate the efficacy of low-dose Decitabine in refractory aplastic anemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Decitabine | Demethylating agents |
Timeline
- Start date
- 2021-04-22
- Primary completion
- 2022-07-26
- Completion
- 2022-08-09
- First posted
- 2021-04-22
- Last updated
- 2026-02-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04854889. Inclusion in this directory is not an endorsement.